SPINT2 goat polyclonal antibody, Aff - Purified
| Applications | ELISA, WB |
| Reactivities | Bovine, Canine, Human, Mouse, Rat |
Antibodies
Canine IgM (Fc specific) goat polyclonal antibody, Azide Free
| Applications | As unlabelled primary or secondary reagent for indirect detection techniques, to prepare conjugates with markers of the user’s own choice, to prepare an insoluble immunoaffinity adsorbent or a solid phase antibody reagent by coupling to an artificial carrier and as catching or detection antibody in non-isotopic methodology and solid phase immunochemistry. When applied in any cytochemical or histochemical procedure or solids phase coupling technique, the optimum concentration of the IgG preparation should always be established by titration. Typical working dilutions: In histochemistry are usually between 1/50 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/500 and 1/3000. |
| Reactivities | Canine |
| Conjugation | Unconjugated |
Canine IgM (Fc specific) goat polyclonal antibody, Biotin
| Applications | Can be used in immunocytochemical and immunohistochemical use for the detection of IgM at the cellular and subcellular level by staining of appropriately treated cell and tissue substrates; to demonstrate circulating IgM antibodies in serodiagnostic microbiology and autoimmune diseases; to identify a specific antigen using an reference antibody of goat origin known to be of the IgM isotype in the middle layer of the indirect test procedure; in non-isotopic assay methodology (e.g. ELISA) to measure IgM in dog serum or other body fluids. As a second step an avidin or streptavidin conjugate of the user’s choice has to be used. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions: For histochemical and cytochemical use are usually between 1/100 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/1000 and 1/4000. |
| Reactivities | Canine |
| Conjugation | Biotin |
RNF34 rabbit polyclonal antibody, Purified
| Applications | ELISA, WB |
| Reactivities | Bovine, Canine, Human, Mouse, Primate, Rat |
ROBO3 goat polyclonal antibody, Aff - Purified
| Applications | ELISA, FC |
| Reactivities | Canine, Human |
PARP12 goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IF |
| Reactivities | Canine, Human |
BCOR (N-term) goat polyclonal antibody, Aff - Purified
| Applications | ChIP, ELISA |
| Reactivities | Bovine, Canine, Human, Mouse, Porcine |
CDKAL1 goat polyclonal antibody, Aff - Purified
| Applications | ELISA, WB |
| Reactivities | Canine, Human, Mouse, Rat |
FOXB1 (C-term) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IF |
| Reactivities | Bovine, Canine, Human, Mouse, Rat |
SEM1 goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IF |
| Reactivities | Bovine, Canine, Human, Mouse, Porcine |
TRPC6 (C-term) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, FC |
| Reactivities | Bovine, Canine, Human, Mouse, Porcine |
Stromal interaction molecule 1 (STIM1) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, WB |
| Reactivities | Canine, Human, Mouse, Rat |
UHRF1 (C-term) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, WB |
| Reactivities | Canine, Human, Mouse, Rat |
FYB1 goat polyclonal antibody, Aff - Purified
| Applications | ELISA, WB |
| Reactivities | Bovine, Canine, Human |
NIR2 (PITPNM1) (C-term) goat polyclonal antibody, Aff - Purified
| Applications | IF, WB |
| Reactivities | Bovine, Canine, Human, Mouse |
活动过滤器
优化搜索结果
Target Symbol
- CALNEXIN (5)
- GAPDH (5)
- RAB27A (5)
- ATAXIN 3 (4)
- CHM (4)
- ERP57 (4)
- GJA1 (4)
- HCRT (4)
- ALPHA TUBULIN (3)
- CALCA (3)
- HIF-1 ALPHA (3)
- MLN (3)
- PYY (3)
- RAB11A (3)
- RAB5 (3)
- SAE1 (3)
- TJP1 (3)
- BMI1 (2)
- CASPASE 3 (2)
- CASPASE 9 (2)
- CATHEPSIN D (2)
- CD19 (2)
- CD45 (2)
- CD63 (2)
- CDC27 (2)
- CLDN1 (2)
- DMTF1 (2)
- E CADHERIN (2)
- EPM2AIP1 (2)
- FBXO9 (2)
- FZD9 (2)
- GAD67 (2)
- GAP43 (2)
- GFAP (2)
- HDAC7A (2)
- HDAC9 (2)
- IDH1 (2)
- KCNIP3 (2)
- KIT (2)
- MAPK9 (2)
- MAPKAPK5 (2)
- NQO1 (2)
- P53 (2)
- POU2AF1 (2)
- POU2F2 (2)
- PPARG (2)
- PSMB4 (2)
- RAB14 (2)
- RAB1B (2)
- RAB7 (2)
- RAB9A (2)
- ROBO1 (2)
- RPS6KA1 (2)
- SNCA (2)
- SOD2 (2)
- TIMP3 (2)
- TNNI3 (2)
- UCHL1 (2)
- 14-3-3 SIGMA (1)
- 5HT7 RECEPTOR (1)
- ABCB1 (1)
- ACADVL (1)
- ACTIVIN RECEPTOR TYPE IA (1)
- AGGRECAN (1)
- AGRP (1)
- AIF (1)
- AIRE (1)
- ALB (1)
- ALBUMIN (1)
- ALDH5A1 (1)
- ALDH6A1 (1)
- ALG2 (1)
- AMPD1 (1)
- ANGIOMOTIN LIKE 1 (1)
- ANKRD32 (1)
- ANNEXIN A1 (1)
- AOC2 (1)
- AP3D1 (1)
- APG12 (1)
- APOLIPOPROTEIN H (1)
- APP (1)
- ARHGEF11 (1)
- ATF6 (1)
- ATG16L1 (1)
- ATP6AP1 (1)
- AXIN1 (1)
- BAG5 (1)
- BAG6 (1)
- BAX (1)
- BBS4 (1)
- BBS7 (1)
- BCL2 (1)
- BCOR (1)
- BECLIN 1 (1)
- BEND5 (1)
- BETA ACTIN (1)
- BETA ARRESTIN 2 (1)
- BETA CATENIN (1)
- BETA V TUBULIN (1)
- BLBP (1)
Applications
Antibody Hosts
Conjugates
Assay Types
Families
- Druggable Genome (187)
- Transmembrane (65)
- Transcription Factors (43)
- ES Cell Differentiation/IPS (28)
- Secreted Protein (20)
- Stem cell - Pluripotency (12)
- Protein Kinase (11)
- Protease (10)
- GPCR (5)
- Adult stem cells (4)
- Ion Channels: Other (4)
- Phosphatase (4)
- Stem cell relevant signaling - JAK/STAT signaling pathway (4)
- Embryonic stem cells (3)
- Induced pluripotent stem cells (3)
- Cancer stem cells (2)
- Ion Channels: Cys-loop Receptors (2)
- Ion Channels: Potassium (2)
- Ion Channels: Transient receptor potential (2)
- Nuclear Hormone Receptor (2)
- P450 (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
Pathways
- Pathways in cancer (26)
- Metabolic pathways (18)
- Endocytosis (15)
- Amyotrophic lateral sclerosis (ALS) (14)
- MAPK signaling pathway (12)
- Adherens junction (11)
- Alzheimer's disease (11)
- Antigen processing and presentation (11)
- Apoptosis (11)
- Colorectal cancer (11)
- Endometrial cancer (11)
- Focal adhesion (11)
- Gap junction (11)
- Cell adhesion molecules (CAMs) (10)
- Huntington's disease (10)
- Pancreatic cancer (10)
- Pathogenic Escherichia coli infection (10)
- Prostate cancer (10)
- Bladder cancer (9)
- p53 signaling pathway (9)
- Calcium signaling pathway (8)
- Cytokine-cytokine receptor interaction (8)
- Non-small cell lung cancer (8)
- T cell receptor signaling pathway (8)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (7)
- Neuroactive ligand-receptor interaction (7)
- Renal cell carcinoma (7)
- VEGF signaling pathway (7)
- Wnt signaling pathway (7)
- Cell cycle (6)
- Epithelial cell signaling in Helicobacter pylori infection (6)
- Lysosome (6)
- Melanoma (6)
- Natural killer cell mediated cytotoxicity (6)
- Neurotrophin signaling pathway (6)
- Parkinson's disease (6)
- Small cell lung cancer (6)
- Thyroid cancer (6)
- Tight junction (6)
- Type I diabetes mellitus (6)
- Viral myocarditis (6)
- mTOR signaling pathway (6)
- Glycolysis / Gluconeogenesis (5)
- Hematopoietic cell lineage (5)
- Insulin signaling pathway (5)
- Leukocyte transendothelial migration (5)
- Primary immunodeficiency (5)
- Progesterone-mediated oocyte maturation (5)
- Toll-like receptor signaling pathway (5)
- Acute myeloid leukemia (4)
- Adipocytokine signaling pathway (4)
- Alanine (4)
- B cell receptor signaling pathway (4)
- Basal cell carcinoma (4)
- Chemokine signaling pathway (4)
- Glioma (4)
- GnRH signaling pathway (4)
- Jak-STAT signaling pathway (4)
- Oocyte meiosis (4)
- RIG-I-like receptor signaling pathway (4)
- Regulation of actin cytoskeleton (4)
- TGF-beta signaling pathway (4)
- Vibrio cholerae infection (4)
- aspartate and glutamate metabolism (4)
- Allograft rejection (3)
- Axon guidance (3)
- Butanoate metabolism (3)
- Chronic myeloid leukemia (3)
- Dilated cardiomyopathy (3)
- ErbB signaling pathway (3)
- Fc epsilon RI signaling pathway (3)
- Fc gamma R-mediated phagocytosis (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- Maturity onset diabetes of the young (3)
- Melanogenesis (3)
- NOD-like receptor signaling pathway (3)
- PPAR signaling pathway (3)
- Proteasome (3)
- Regulation of autophagy (3)
- Ribosome (3)
- Type II diabetes mellitus (3)
- beta-Alanine metabolism (3)
- Asthma (2)
- Citrate cycle (TCA cycle) (2)
- Dorso-ventral axis formation (2)
- ECM-receptor interaction (2)
- Long-term depression (2)
- Long-term potentiation (2)
- Phosphatidylinositol signaling system (2)
- Prion diseases (2)
- Systemic lupus erythematosus (2)
- Taurine and hypotaurine metabolism (2)
- Ubiquitin mediated proteolysis (2)
- Vascular smooth muscle contraction (2)
- Arachidonic acid metabolism (1)
- Arginine and proline metabolism (1)
- Autoimmune thyroid disease (1)
- Basal transcription factors (1)
- Base excision repair (1)
- D-Glutamine and D-glutamate metabolism (1)
- Ether lipid metabolism (1)
- Glutathione metabolism (1)
- Glycerophospholipid metabolism (1)
- Glycine (1)
- Graft-versus-host disease (1)
- Hedgehog signaling pathway (1)
- Histidine metabolism (1)
- Methane metabolism (1)
- N-Glycan biosynthesis (1)
- Nitrogen metabolism (1)
- Olfactory transduction (1)
- One carbon pool by folate (1)
- Oxidative phosphorylation (1)
- Phenylalanine metabolism (1)
- Porphyrin and chlorophyll metabolism (1)
- Purine metabolism (1)
- Pyruvate metabolism (1)
- RNA degradation (1)
- Retinol metabolism (1)
- SNARE interactions in vesicular transport (1)
- Spliceosome (1)
- Tryptophan metabolism (1)
- Tyrosine metabolism (1)
- serine and threonine metabolism (1)
